Groupama Asset Managment lessened its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 81.4% during the fourth quarter, Holdings Channel reports. The fund owned 1,111 shares of the semiconductor company’s stock after selling 4,857 shares during the period. Groupama Asset Managment’s holdings in Synopsys were worth $541,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in the company. Trexquant Investment LP bought a new stake in Synopsys in the 4th quarter worth approximately $17,792,000. Boston Family Office LLC raised its stake in shares of Synopsys by 1.0% during the fourth quarter. Boston Family Office LLC now owns 4,405 shares of the semiconductor company’s stock worth $2,138,000 after acquiring an additional 42 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Synopsys by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 3,357,165 shares of the semiconductor company’s stock worth $1,625,230,000 after acquiring an additional 75,298 shares during the last quarter. B. Metzler seel. Sohn & Co. AG boosted its stake in shares of Synopsys by 6.3% in the 4th quarter. B. Metzler seel. Sohn & Co. AG now owns 97,680 shares of the semiconductor company’s stock valued at $47,419,000 after purchasing an additional 5,773 shares in the last quarter. Finally, Edmond DE Rothschild Holding S.A. grew its holdings in shares of Synopsys by 14.7% during the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 25,863 shares of the semiconductor company’s stock valued at $12,553,000 after purchasing an additional 3,321 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Analysts Set New Price Targets
Several analysts have issued reports on SNPS shares. Rosenblatt Securities restated a “buy” rating and set a $660.00 price target on shares of Synopsys in a research report on Tuesday, February 25th. Needham & Company LLC restated a “buy” rating and set a $650.00 target price on shares of Synopsys in a report on Thursday, February 27th. Robert W. Baird decreased their price target on Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. Redburn Atlantic started coverage on Synopsys in a research note on Monday, January 13th. They set a “buy” rating and a $600.00 price objective for the company. Finally, Morgan Stanley decreased their target price on shares of Synopsys from $625.00 to $590.00 and set an “overweight” rating on the stock in a research note on Monday, February 24th. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, Synopsys has a consensus rating of “Moderate Buy” and a consensus target price of $638.58.
Synopsys Stock Down 4.7 %
NASDAQ:SNPS opened at $417.76 on Friday. Synopsys, Inc. has a twelve month low of $404.08 and a twelve month high of $624.80. The stock has a market cap of $64.59 billion, a P/E ratio of 28.77, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16. The firm’s fifty day simple moving average is $476.99 and its 200 day simple moving average is $503.85.
Insider Activity at Synopsys
In related news, insider Geus Aart De sold 15,705 shares of Synopsys stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the sale, the insider now directly owns 116,671 shares in the company, valued at $51,850,925.82. The trade was a 11.86 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the transaction, the executive now owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 47,909 shares of company stock worth $22,794,835 over the last 90 days. 0.62% of the stock is owned by company insiders.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Market Cap Calculator: How to Calculate Market Cap
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Following Congress Stock Trades
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- What is diluted earnings per share (Diluted EPS)?
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.